[1]王术江综述,李伟彦审校.阿片类药物在癌痛治疗的剂量滴定与转换[J].医学研究与战创伤救治(原医学研究生学报),2016,18(05):522-526.[doi:10.3969/j.issn.1672-271X.2016.05.022]

点击复制

阿片类药物在癌痛治疗的剂量滴定与转换()

分享到62.8K

参考文献/References:

[1]张帆,闵苏.阿片类药物滴定及转换在癌痛治疗中的研究进展[J].国际麻醉学与复苏杂志，2015,36（8）：737-740.
[2]孟勇,陆文汉,段满林.瑞芬太尼用于心脏手术麻醉的进展[J].医学研究生学报,2010,23(7):779-782.
[3]王玲,姜荣荣,刘云.癌性疼痛的评估与护理[J].医学研究生学报,2011,24(2):221-224.
[4]Mcgivney WT.NCCN:your best resource in the fight against cancer[J].J Natl compr Canc Netw,2015,13(2):125-126.
[5]Klepstad P,Kaasa S,Jystad A,et al.Immediat-orsustained-release,morphine for dose finding during start of morphine to cancer patients:arandomized,double-blindtrial[J].Pain,2003,101(1-2):193-198.
[6]刘红军,朱红梅,程祝强,等.吗啡和曲马多对MADB乳腺癌细胞增殖和凋亡的影响[J].东南国防医药，2014,16（5）：449-452.
[7]吴庆欢,邱海峰,梁丹,等.2007年我院癌痛者使用吗啡制剂调查分析 [J].中国医药导报，2008,5（12）：105-112.
[8]Salzman RT,Roberts MS,Wild J,et al.Can a controlled-re-lease oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control[J].Pain Symptom Manaye,1999,18(4):271-279.
[9]Therry C,Boeynaems M,Paolom M.Action of tilidine and nortilidine on cloned opiooid receptors[J].Eur J Phamacol,2005,506(3):205-208.
[10]孙莉,李潇潇,梁军成,等.盐酸替利定口服液用于镇痛的随机双盲对照临床试验[J].中国临床药理学杂志，2013,29（1）：6-8.
[11]NCB Trends in the licitmovement of narcotic drugs Narcotic Drugs Estimated world requipments for 2001 [R].United Nations New York 2001.
[12]梁晓华.癌痛镇痛药物的规范应用[J].医药综述，2011,32（12）：585-588.
[13]Caraceni A, Hanks G,Kaasa S, et al.Use of opioid analgesics in the treatment of cancer pain:evidence-based recommendations from the EAPC[J].Lancet Oncol,2012,13(2):58-68.
[14]Ackerman SJ,Knight T,Schein J,et al.Risk of constipation in patients presctibed fentanyl transdermal system or oxycodone hydrochloride controlled-release in a California Medicaid population[J].Consult Pharm,2004,19(2):118-132.
[15]Anderson R,Saiers JH,Abram S,et al.Accuracy in equianalgesic dosing.nversion dilemmas[J].J Pain Symptom Manage,2001,21(5):397-406.
[16]Heiskanen T,Kalso E.Controlled-release oxycodone and morphine in cancer related pain[J].Pain,1997,73(1):37-45.
[17]Portenoy RK,Ahmed E.Principles of opioin use in cancer pain[J].J Clin Oncol,2014,32(16):1662-1670.
[18]Ripamonti CI,Bandieri E,Roila F.ESMO Guidelines Working Group.Management of cancer pain: ESMO Clinical Practice Guidelines[J].Ann Oncol,2011,22(6):69-77.
[19]Sato C,Okabe T,Nakanishi K,et al.A case of cancer pain management by long-term intrathecai PCA[J].Nihon Med Sch,2010,77(6):333-337.
[20]Yi-Feng Z,Li-Ming J,Wei-Min M,et al. Percutaneous computed tomography-guided lung biopsy of solitary nodular ground-glass opacity[J].Cancer Res Ther,2015, 11(11):231-233.
[21]何敏琪，吴曙粤.晚期癌症病人镇痛治疗进展 [J]. 广西医学，2011,33（1）：95-98.
[22]杨冯睿，倪家骧.鞘内给药治疗疼痛进展 [J]. 疑难病杂志，2012,3（11）：232-234.
[23]王昆.鞘内输注系统治疗顽固性癌痛 [J]. 中国肿瘤临床，2013,40（18）：1141-1144.
[24]程乐，钟进才.阿片类药物应用于中、重度癌痛治疗的研究进展[J]. 广西药学杂志，2009,31（5）：742-745.

相似文献/References: